Labcorp's Q1 Earnings: Can They Beat Peer Beats?

Labcorps Q1 earnings, set to drop this Thursday, are under investor scrutiny. Analysts predict a 4.8% year-over-year revenue increase, matching last years growth. Despite missing revenue targets last quarter, Labcorps stock is down 2.6% in the past month, lagging peers like NeoGenomics and Quest Diagnostics. Analysts see potential upside, with an average price target of $310.60. Keep an eye on Labcorps performance to see if they can surprise and turn the tide. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/6ea64858c45baf70